Authors: CONNOR TH

Citation: Th. Connor, MUTAGENICITY OF COSMETIC PRODUCTS CONTAINING KATHON(R) (VOL 28, PG 127, 1997), Environmental and molecular mutagenesis, 29(3), 1997, pp. 330-330

Authors: BAKER ES CONNOR TH

Citation: Es. Baker et Th. Connor, MONITORING OCCUPATIONAL EXPOSURE TO CANCER-CHEMOTHERAPY DRUGS, American journal of health-system pharmacy, 53(22), 1996, pp. 2713-2723

Authors: WU XF SPITZ MR DELCLOS GL CONNOR TH ZHAO Y SICILIANO MJ HSU TC

Citation: Xf. Wu et al., SURVIVAL OF CELLS WITH BLEOMYCIN-INDUCED CHROMOSOMAL LESIONS IN THE CULTURED LYMPHOCYTES OF LUNG-CANCER PATIENTS, Cancer epidemiology, biomarkers & prevention, 5(7), 1996, pp. 527-532

Authors: CONNOR TH

Citation: Th. Connor, PERMEABILITY TESTING OF GLOVE MATERIALS FOR USE WITH CANCER-CHEMOTHERAPY DRUGS, Oncology, 52(3), 1995, pp. 256-259

Authors: BENVENUTO JA CONNOR TH MONTEITH DK LAIDLAW JL ADAMS SC MATNEY TS THEISS JC

Citation: Ja. Benvenuto et al., DEGRADATION AND INACTIVATION OF ANTITUMOR DRUGS, Journal of pharmaceutical sciences, 82(10), 1993, pp. 988-991